MODIFIED LAMININ CONTAINING COLLAGEN BINDING MOLECULE AND USE THEREOF

A modified laminin characterized in that a laminin or a heterotrimeric laminin fragment has a collagen binding molecule conjugated to at least one site selected from the ± chain N-terminus, the ² chain N-terminus and the ³ chain N-terminus, and an extracellular-matrix material comprising the modifie...

Full description

Saved in:
Bibliographic Details
Main Authors SATO, Ryoko, SEKIGUCHI, Kiyotoshi, LI, Shaoliang
Format Patent
LanguageEnglish
French
German
Published 10.04.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A modified laminin characterized in that a laminin or a heterotrimeric laminin fragment has a collagen binding molecule conjugated to at least one site selected from the ± chain N-terminus, the ² chain N-terminus and the ³ chain N-terminus, and an extracellular-matrix material comprising the modified laminin, and collagen and/or gelatin serve as an alternative to Matrigel and are useful as an extracellular-matrix material for the formation of a safe three-dimensional tissue structure for regenerative medicine in humans.
Bibliography:Application Number: EP20130866723